NCT00765193
- Conditions
- Adenocarcinoma, Basal Cell Carcinoma, Carcinoma, +27 more
- Locations
-
- Medical University of Graz-Austria: Department of Dermatology Graz, Austria
Clinical trial condition
Basal Cell Carcinoma
Explore clinical trials studying Basal Cell Carcinoma. Study availability and eligibility vary by location and protocol.
142 public trials
19 recruiting studies
Basal Cell Carcinoma trial results
NCT00985829
- Conditions
- Basal Cell Carcinoma, Carcinoma, Carcinoma, Basal Cell, +4 more
- Locations
-
Not specified
NCT01015898
- Conditions
- Basal Cell Carcinoma, Carcinoma, Carcinoma, Basal Cell, +4 more
- Locations
-
Not specified
Completed
Evaluation of Efficacy of Photodynamic Therapy in Basal Cell Carcinoma With 6 Months Follow-up
NCT00988455
- Conditions
- Basal Cell Carcinoma, Carcinoma, Carcinoma, Basal Cell, +4 more
- Locations
-
Not specified
Completed
Photochemical Tissue Bonding
NCT00586040
- Conditions
- Atypical Nevus, Basal Cell Carcinoma, Carcinoma, +18 more
- Locations
-
- Massachusetts General Hospital Boston, Massachusetts, United States
NCT00108134
- Conditions
- Basal Cell Carcinoma, Carcinoma, Carcinoma, Basal Cell, +4 more
- Locations
-
- Southderm Pty Ltd Sydney, New South Wales, Australia
- St George Dermatology & Skin Cancer Centre Sydney, New South Wales, Australia
- Siller Medical Brisbane, Queensland, Australia
- Belmont Specialist Centre Brisbane, Queensland, Australia
NCT00005660
- Conditions
- Basal Cell Carcinoma, Carcinoma, Carcinoma, Basal Cell, +30 more
- Locations
-
- National Cancer Institute (NCI) Bethesda, Maryland, United States
Active, Not Recruiting
Study Comparing the Standard Administration of IO Versus the Same IO Administered Each 3 Months in Patients in Response After 6 Months of Standard IO
NCT05078047
- Conditions
- Adenocarcinoma, Basal Cell Carcinoma, Breast Diseases, +69 more
- Locations
-
- Institut de cancérologie de l'Ouest Angers, France
- Clinique Sainte Catherine Avignon, France
- Centre Hospitalier de la Côte Basque Bayonne, France
- CHU Bordeaux - Hôpial Saint André Bordeaux, France
Active, Not Recruiting
In Situ Immunomodulation With CDX-301, Radiation Therapy, CDX-1140 and Poly-ICLC in Patients w/ Unresectable and Metastatic Solid Tumors
NCT04616248
- Conditions
- Adenocarcinoma, Anatomic Stage IV Breast Cancer AJCC v8, Basal Cell Carcinoma, +44 more
- Locations
-
- Los Angeles General Medical Center Los Angeles, California, United States
- USC/Norris Comprehensive Cancer Center Los Angeles, California, United States
Active, Not Recruiting
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
NCT02834013
- Conditions
- Acinar Cell Carcinoma, Adenocarcinoma, Adenocarcinoma of Lung, +207 more
- Locations
-
- University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
- University of South Alabama Mitchell Cancer Institute Mobile, Alabama, United States
- Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
- Anchorage Radiation Therapy Center Anchorage, Alaska, United States